Correction to: BMC Neurol (2019) 19:287
https://doi.org/10.1186/s12883-019-1506-0
Following publication of the original article [1], an error was noted regarding the year found in the paragraph of the Background section.
The sentence should read ‘As of 31 August 2019, it is estimated that more than 293,400 patients have been treated with fingolimod, corresponding to approximately 714,600 patient-years of exposure (data on file, Novartis Pharmaceuticals Corporation)’.
Reference
Brown B, Weiss JL, Kolodny S, Meng X, Williams IM, Osborne JA. Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic. BMC Neurol. 2019;19:287. https://doi.org/10.1186/s12883-019-1506-0.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Brown, B., Weiss, J.L., Kolodny, S. et al. Correction to: Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic. BMC Neurol 19, 336 (2019). https://doi.org/10.1186/s12883-019-1568-z
Published:
DOI: https://doi.org/10.1186/s12883-019-1568-z